Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mario Ernest
Relationship:   Director
City:   Redwood City
State:   CA
   
Insider Summary:
  
   
Companies Owned :   13    
Direct Shares   1,151,697    

Indirect Shares

   265,510      
Direct Value   $8,388,670    

Indirect Value

   $113,731      
Total Shares   1,417,207      
Total Value   $8,502,401      


Maxygen Inc $0 Ardea Biosciences Inc $0 Boston Scientific Corp $6,506,600 Alexza Pharmaceuticals Inc. $0 Vivus Inc $9,524 Xenoport Inc $0 Chimerix Inc $12,105 Kindred Biosciences, Inc. $1,563,250 Soleno Therapeutics Inc $29,925 Eyenovia Inc $267,266 Maxygen Inc $0 Ardea Biosciences Inc $0 Boston Scientific Corp $6,506,600 Alexza Pharmaceuticals Inc. $0 Vivus Inc $9,524 Xenoport Inc $0 Chimerix Inc $12,105 Kindred Biosciences, Inc. $1,563,250 Soleno Therapeutics Inc $29,925 Eyenovia Inc $267,266
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -41.7%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Maxygen Inc MAXY Director 2012-06-06 62,964 2003-08-05 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2004-05-05 70,431 2004-05-05 85,554    Premium*  
            Pharmaceutical Product Developme... PPDI Director 2011-12-05 0 2011-12-05 0    Premium*  
            Boston Scientific Corp BSX Director 2015-11-16 86,032 2013-11-08 0    Premium*  
            Alexza Pharmaceuticals Inc. ALXA Director 2006-03-08 18,181 0    Premium*  
            Celgene Corp CELG 2019-11-20 0 2019-11-20 0    Premium*  
            Vivus Inc VVUS Director 2013-05-29 81,125 2012-04-25 0    Premium*  
            Xenoport Inc XNPT Director 2015-05-19 88,750 2012-08-09 0    Premium*  
            Tonix Pharmaceuticals Holding Corp TNXP Director 2018-02-09 0 2018-06-25 50,000    Premium*  
            Chimerix Inc CMRX Director 2018-05-18 12,905 2018-05-18 108,167    Premium*  
            Kindred Biosciences, Inc. KIN Director 2018-10-29 169,000 2013-12-12 0    Premium*  
            Soleno Therapeutics Inc SLNO 2024-05-21 186,566 2024-05-21 21,789    Premium*  
            Eyenovia Inc EYEN Director 2021-01-15 375,743 2018-07-24 0    Premium*  
* Premium Members only  

Records found :    373         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 13 of 15
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SLNO Soleno Therapeutics Inc Director   –       •      –    2017-10-02 4 A $0.52 $15,000 D/D 28,846 1,873,174 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2018-02-05 4 A $1.73 $15,000 D/D 8,689 704,352 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-05-18 4 A $1.90 $47,500 D/D 25,000 408,324 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-05-21 4 A $1.94 $58,470 D/D 30,000 438,324 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-05-25 4 A $2.05 $10,250 D/D 5,000 443,324 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-05-29 4 A $2.01 $1,005 D/D 500 443,824 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-05-31 4 A $2.05 $1,025 D/D 500 444,324 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-06-01 4 A $2.05 $2,665 D/D 1,300 445,624 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-06-05 4 A $2.05 $2,460 D/D 1,200 446,824 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-06-07 4 A $2.00 $9,234 D/D 4,611 451,435 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-06-08 4 A $2.04 $30,257 D/D 14,803 466,238 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-06-11 4 A $2.04 $11,229 D/D 5,480 471,718 0 -
SLNO Soleno Therapeutics Inc Director   –       •       •   2018-06-13 4 A $2.04 $7,356 D/D 3,606 475,324 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2020-01-22 4 A $3.35 $35,001 D/D 10,448 10,448 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2020-04-30 4 A $3.05 $17,501 D/D 5,738 5,738 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2020-07-31 4 A $1.72 $17,499 D/D 10,174 10,174 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2020-10-30 4 A $1.74 $17,499 D/D 10,057 1,148,876 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2021-01-29 4 A $0.00 $0 D/D 8,928 1,157,804 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2021-04-30 4 A $1.21 $20,000 D/D 16,529 1,176,416 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2021-07-30 4 A $0.91 $20,000 D/D 21,978 1,349,909 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2021-10-29 4 A $0.00 $0 D/D 26,888 1,376,797 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2022-01-31 4 A $0.36 $20,000 D/D 56,338 1,433,135 0 -
SLNO Soleno Therapeutics Inc Director   –       •      –    2022-03-31 4 B $0.00 $0 I/I 930,000 930,000 2.02 %
SLNO Soleno Therapeutics Inc Director   –       •      –    2022-03-31 4 B $0.00 $0 D/D 930,000 2,363,135 2.31 %
SLNO Soleno Therapeutics Inc Director   –       •      –    2023-11-30 4 GD $0.00 $0 D/D 8,700 128,089 0 -
  373  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13  14   15      
  Page 13 of 15  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us